logo
AI Icon𝛼SK or Search
ENTITY

Orum Therapeutics (475830 KS)

10
Analysis
Health Care • South Korea
Orum Therapeutics, Inc. operates as a clinical stage biotech company. The Company develops cell-penetrating antibodies, biomedical therapy applications, and pharmaceuticals for cancer and immune diseases. Orum Therapeutics serves clients worldwide.
more
Exchange Announcement • 18 Sep 2026 13:50

Material Management Information related to Judgment of Investment(Termination of the Asset Purchase Agreement (APA) Following Bristol Myers Squibb's (BMS) Discontinuation of Clinical Development of BMS-986497 (ORM-6151))

Exchange Announcement • 17 Sep 2026 17:08

Material Management Information related to Judgment of Investment(Bristol Myers Squibb(BMS)의 BMS-986497(ORM-6151) 임상 중단에 따른 자산양수도 계약 ì¢ ë£Œ)

Exchange Announcement • 10 Sep 2026 18:06

Closure of Register of Shareholders or Designation of Record Date

Exchange Announcement • 10 Sep 2026 18:00

Resolutions for Convocation of General Meeting of Shareholders(임시주주총회)

Exchange Announcement • 10 Sep 2026 17:51

Resolutions for Convocation of General Meeting of Shareholders(임시주주총회)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x